Cargando…
Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System
INTRODUCTION: We have evaluated the performance of the FreeStyle Libre® 3 continuous glucose monitoring system (FSL3) compared to (1) the venous plasma reference for participants aged ≥ 6 years and (2) the fingerstick capillary blood glucose (BG) reference for pediatric participants aged 4 and 5 yea...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064376/ https://www.ncbi.nlm.nih.gov/pubmed/36877403 http://dx.doi.org/10.1007/s13300-023-01385-6 |
_version_ | 1785017887246778368 |
---|---|
author | Alva, Shridhara Brazg, Ronald Castorino, Kristin Kipnes, Mark Liljenquist, David R. Liu, Hanqing |
author_facet | Alva, Shridhara Brazg, Ronald Castorino, Kristin Kipnes, Mark Liljenquist, David R. Liu, Hanqing |
author_sort | Alva, Shridhara |
collection | PubMed |
description | INTRODUCTION: We have evaluated the performance of the FreeStyle Libre® 3 continuous glucose monitoring system (FSL3) compared to (1) the venous plasma reference for participants aged ≥ 6 years and (2) the fingerstick capillary blood glucose (BG) reference for pediatric participants aged 4 and 5 years. The analytical performance of the third-generation factory-calibrated FSL3 CGM system was compared to the plasma venous blood glucose reference using the YSI 2300 STAT PLUS Glucose and Lactate Analyzer (the YSI reference) and the self-monitoring blood glucose (SMBG) reference for participants aged ≥ 6 years and participants aged 4 and 5 years, respectively. METHODS: A total of 108 participants aged ≥ 4 years with type 1 or type 2 diabetes from four sites in the USA were enrolled in the study. The data of 100 participants were ultimately evaluated. Adult participants (aged ≥ 18 years) participated in three in-clinic sessions, and pediatric participants (aged 4–17 years) participated in up to two in-clinic sessions, all stratified to provide data for days 1, 2, 3, 7, 8, 9, 12, 13 or 14 of sensor wear. Performance evaluation included accuracy measures, such as proportion of CGM values that fell within ± 20% or ± 20 mg/dL (1.1 mmol/L) of the reference glucose values, and difference measures, such as the mean absolute relative difference (MARD) between the CGM and reference values. RESULTS: Data from the 100 study participants were analyzed. The overall MARD was 7.8%, and 93.4% of the CGM values were within ± 20% or ± 20 mg/dL of the YSI reference for participants aged ≥ 6 years, with 6845 CGM-YSI matched pairs. The performance was stable over the 14-day wear period. For participants aged 4–5 years, MARD was 10.0%, and 88.9% of the CGM values were within 20%/20 mg/dL compared to a SMBG reference. No serious adverse events were reported. CONCLUSIONS: The FSL3 CGM system demonstrated accurate performance across the dynamic glycemic range during the 14-day sensor wear period. |
format | Online Article Text |
id | pubmed-10064376 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-100643762023-04-01 Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System Alva, Shridhara Brazg, Ronald Castorino, Kristin Kipnes, Mark Liljenquist, David R. Liu, Hanqing Diabetes Ther Original Research INTRODUCTION: We have evaluated the performance of the FreeStyle Libre® 3 continuous glucose monitoring system (FSL3) compared to (1) the venous plasma reference for participants aged ≥ 6 years and (2) the fingerstick capillary blood glucose (BG) reference for pediatric participants aged 4 and 5 years. The analytical performance of the third-generation factory-calibrated FSL3 CGM system was compared to the plasma venous blood glucose reference using the YSI 2300 STAT PLUS Glucose and Lactate Analyzer (the YSI reference) and the self-monitoring blood glucose (SMBG) reference for participants aged ≥ 6 years and participants aged 4 and 5 years, respectively. METHODS: A total of 108 participants aged ≥ 4 years with type 1 or type 2 diabetes from four sites in the USA were enrolled in the study. The data of 100 participants were ultimately evaluated. Adult participants (aged ≥ 18 years) participated in three in-clinic sessions, and pediatric participants (aged 4–17 years) participated in up to two in-clinic sessions, all stratified to provide data for days 1, 2, 3, 7, 8, 9, 12, 13 or 14 of sensor wear. Performance evaluation included accuracy measures, such as proportion of CGM values that fell within ± 20% or ± 20 mg/dL (1.1 mmol/L) of the reference glucose values, and difference measures, such as the mean absolute relative difference (MARD) between the CGM and reference values. RESULTS: Data from the 100 study participants were analyzed. The overall MARD was 7.8%, and 93.4% of the CGM values were within ± 20% or ± 20 mg/dL of the YSI reference for participants aged ≥ 6 years, with 6845 CGM-YSI matched pairs. The performance was stable over the 14-day wear period. For participants aged 4–5 years, MARD was 10.0%, and 88.9% of the CGM values were within 20%/20 mg/dL compared to a SMBG reference. No serious adverse events were reported. CONCLUSIONS: The FSL3 CGM system demonstrated accurate performance across the dynamic glycemic range during the 14-day sensor wear period. Springer Healthcare 2023-03-06 2023-04 /pmc/articles/PMC10064376/ /pubmed/36877403 http://dx.doi.org/10.1007/s13300-023-01385-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Research Alva, Shridhara Brazg, Ronald Castorino, Kristin Kipnes, Mark Liljenquist, David R. Liu, Hanqing Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System |
title | Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System |
title_full | Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System |
title_fullStr | Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System |
title_full_unstemmed | Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System |
title_short | Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System |
title_sort | accuracy of the third generation of a 14-day continuous glucose monitoring system |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10064376/ https://www.ncbi.nlm.nih.gov/pubmed/36877403 http://dx.doi.org/10.1007/s13300-023-01385-6 |
work_keys_str_mv | AT alvashridhara accuracyofthethirdgenerationofa14daycontinuousglucosemonitoringsystem AT brazgronald accuracyofthethirdgenerationofa14daycontinuousglucosemonitoringsystem AT castorinokristin accuracyofthethirdgenerationofa14daycontinuousglucosemonitoringsystem AT kipnesmark accuracyofthethirdgenerationofa14daycontinuousglucosemonitoringsystem AT liljenquistdavidr accuracyofthethirdgenerationofa14daycontinuousglucosemonitoringsystem AT liuhanqing accuracyofthethirdgenerationofa14daycontinuousglucosemonitoringsystem |